
Veracal80 mg
Incepta Pharmaceuticals Ltd.
Verapamil Hydrochloride is a non-dihydropyridine calcium channel blocker used for the following indications and more.
Verapamil Hydrochloride is a non-dihydropyridine calcium channel blocker used for the following indications, classified by strength of evidence:
Verapamil Hydrochloride is frequently combined with a thiazide diuretic, an ACE inhibitor, or a long-acting nitrate when a single agent does not adequately control blood pressure or angina symptoms.
The decision to use Verapamil Hydrochloride for any indication, especially off-label ones, should be individualized by a physician.
Dosage of Verapamil Hydrochloride must be individualized based on indication, formulation, patient response, and tolerability. Typical adult dosing ranges are summarized below; always follow the prescribing physician's instructions.
| Indication | Typical adult dose |
|---|---|
| Hypertension (immediate-release) | 80 mg three times daily, titrated to response (usual range 240-480 mg/day in divided doses) |
| Hypertension (sustained-release) | 120-240 mg once daily, may be increased up to 480 mg/day |
| Chronic stable / vasospastic angina | 80-120 mg three times daily (immediate-release); up to 480 mg/day in divided or sustained-release doses |
| Supraventricular arrhythmia prophylaxis (oral) | 240-480 mg/day in divided doses |
| Acute PSVT (intravenous, adult) | 5-10 mg (0.075-0.15 mg/kg) IV over at least 2 minutes; a repeat dose of 10 mg may be given after 15-30 minutes if needed, under continuous cardiac monitoring |
Dose reduction and careful titration are recommended in patients with hepatic impairment, as Verapamil Hydrochloride clearance is significantly reduced (up to 70% of normal). Caution and slower titration are also advised in significant renal impairment.
If a dose of Verapamil Hydrochloride is missed, it should be taken as soon as remembered unless it is close to the time of the next dose, in which case the missed dose should be skipped. Doses should not be doubled.
Side effects of Verapamil Hydrochloride vary by formulation and dose. Constipation is notably common and characteristic of Verapamil Hydrochloride among calcium channel blockers.
Patients should seek prompt medical attention for signs of very slow heartbeat, severe dizziness/fainting, or worsening shortness of breath while taking Verapamil Hydrochloride.
Verapamil Hydrochloride is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.